Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
BioMarin Pharmaceutical Inc
NASDAQ:BMRN
BioMarin Pharmaceutical Inc
NASDAQ:BMRN
Price:
56.03
USD
-0.16%
Market Closed
Market Cap:
$10.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently viewed
Price
Wall St Price Targets
BMRN Price Forecast
Based on 30 analysts
Based on 30 analysts
+63% Upside
from
$56.03
today
BioMarin Pharmaceutical Inc (BMRN)’s 12-month stock price forecast through November 2027 has a consensus target of $91.45, implying 63% upside. The forecast is based on price targets from 30 Wall Street analysts.
BMRN Analyst Rating
Based on 28 analysts
Based on 28 analysts
Analysts rate BMRN Buy, with 21 of 28 recommending Buy or Strong buy.
BioMarin Pharmaceutical Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BMRN's stock price target?
Price Target
91.45
USD
91.45
USD
According to Wall Street analysts, the average 1-year price target for BMRN is 91.45 USD with a low forecast of 60.6 USD and a high forecast of 128.1 USD.
What is the Revenue forecast for BioMarin Pharmaceutical Inc?
Projected CAGR
9%
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 8 years is 9%.
What is the Gross Profit forecast for BioMarin Pharmaceutical Inc?
Projected CAGR
9%
9%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 8 years is 9%.
What is the Operating Income forecast for BioMarin Pharmaceutical Inc?
Projected CAGR
15%
15%
The compound annual growth rate for Operating Income over the next 8 years is 15%.
What is the Pre-Tax Income forecast for BioMarin Pharmaceutical Inc?
Projected CAGR
47%
47%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 47%.
What is the Net Income forecast for BioMarin Pharmaceutical Inc?
Projected CAGR
25%
25%
The compound annual growth rate for Net Income over the next 8 years is 25%.
